University of Sheffield and Pfizer lead new €25.5 million project to accelerate development of Advanced Therapy Medicinal Products
The University and Pfizer have today launched a new consortium which aims to standardize and accelerate the development of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative treatments to reach patients sooner.
Sheffield clinical trials aim to improve detection and treatment of bladder and prostate cancer
The University of Sheffield has been awarded £3.1million in funding for two major clinical trials to help improve the detection of bladder cancer and treatment of early stage prostate cancer.
£12.2 million boost for Covid-19 genomic surveillance
University of Sheffield researchers will work with partners in the Covid-19 Genomics UK (COG-UK) Consortium to map how COVID-19 spreads and evolves, thanks to a £12.2 million funding boost.
University of Sheffield ranked within the top 100 in the world for clinical and health subjects in the Times Higher Education (THE) World Subject Rankings 2021
The University of Sheffield is one of the world’s leading universities for teaching and research, according to a subject ranking published today (Wednesday 28 October 2020).